These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14711191)

  • 1. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells.
    Nakajima T; Ma J; Iida H; Iwasawa K; Jo T; Omata M; Nagai R
    Jpn Heart J; 2003 Nov; 44(6):963-78. PubMed ID: 14711191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic acid inhibits vasopressin-activated Ca2+ influx and cell proliferation in rat aortic smooth muscle cell lines.
    Asano M; Nakajima T; Iwasawa K; Asakura Y; Morita T; Nakamura F; Tomaru T; Wang Y; Goto A; Toyo-oka T; Soma M; Suzuki S; Okuda Y
    Eur J Pharmacol; 1999 Aug; 379(2-3):199-209. PubMed ID: 10497907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
    Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y
    Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol inhibits vascular smooth muscle cell proliferation.
    Sung CP; Arleth AJ; Ohlstein EH
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):221-7. PubMed ID: 7679155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells.
    Minowa T; Miwa S; Kobayashi S; Enoki T; Zhang XF; Komuro T; Iwamuro Y; Masaki T
    Br J Pharmacol; 1997 Apr; 120(8):1536-44. PubMed ID: 9113376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of extracellular pH on receptor-mediated Ca2+ influx in A7r5 rat smooth muscle cells: involvement of two different types of channel.
    Iwasawa K; Nakajima T; Hazama H; Goto A; Shin WS; Toyo-oka T; Omata M
    J Physiol; 1997 Sep; 503 ( Pt 2)(Pt 2):237-51. PubMed ID: 9306269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of Ca2+ antagonists on two types of Ca2+ channels in rat aorta smooth muscle cells in primary culture.
    Kuga T; Sadoshima J; Tomoike H; Kanaide H; Akaike N; Nakamura M
    Circ Res; 1990 Aug; 67(2):469-80. PubMed ID: 2165445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 and vasopressin activate Ca(2+)-permeable non-selective cation channels in aortic smooth muscle cells: mechanism of receptor-mediated Ca2+ influx.
    Nakajima T; Hazama H; Hamada E; Wu SN; Igarashi K; Yamashita T; Seyama Y; Omata M; Kurachi Y
    J Mol Cell Cardiol; 1996 Apr; 28(4):707-22. PubMed ID: 8732499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells.
    Nakajima T; Kitazawa T; Hamada E; Hazama H; Omata M; Kurachi Y
    Eur J Pharmacol; 1995 Dec; 294(2-3):625-35. PubMed ID: 8750727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol regulation of calcium entry pathways in cultured A10 and rat aortic smooth muscle cells.
    Xuan YT; Glass PS
    Br J Pharmacol; 1996 Jan; 117(1):5-12. PubMed ID: 8825336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+ entry channels involved in contractions of rat aorta induced by endothelin-1, noradrenaline, and vasopressin.
    Furutani H; Zhang XF; Iwamuro Y; Lee K; Okamoto Y; Takikawa O; Fukao M; Masaki T; Miwa S
    J Cardiovasc Pharmacol; 2002 Aug; 40(2):265-76. PubMed ID: 12131556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.
    Ohlstein EH; Douglas SA; Sung CP; Yue TL; Louden C; Arleth A; Poste G; Ruffolo RR; Feuerstein GZ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6189-93. PubMed ID: 8327499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of a new Ca2+ channel antagonist, CD832, on two types of Ca2+ channels in smooth muscle.
    Hirakawa Y; Kuga T; Kanaide H; Takeshita A
    Eur J Pharmacol; 1994 Feb; 252(3):267-74. PubMed ID: 8162949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery.
    Hattori Y; Nakaya H; Endou M; Nakao Y; Kanno M
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):572-9. PubMed ID: 2470994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine blocks Ca2+ store refilling through a pathway not involving L-type Ca2+ channels in rabbit arteriolar smooth muscle.
    Curtis TM; Scholfield CN
    J Physiol; 2001 May; 532(Pt 3):609-23. PubMed ID: 11313433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for capacitative and non-capacitative Ca2+ entry pathways coexist in A10 vascular smooth muscle cells.
    Zhou JG; Qiu QY; Zhang Z; Liu YJ; Guan YY
    Life Sci; 2006 Feb; 78(14):1558-63. PubMed ID: 16236332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture.
    Saijonmaa O; Metsärinne K; Fyhrquist F
    Blood Press; 1997 Jan; 6(1):24-8. PubMed ID: 9116922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes.
    Cheng J; Niwa R; Kamiya K; Toyama J; Kodama I
    Eur J Pharmacol; 1999 Jul; 376(1-2):189-201. PubMed ID: 10440104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple pathways for entry of calcium and other divalent cations in a vascular smooth muscle cell line (A7r5).
    Hughes AD; Schachter M
    Cell Calcium; 1994 Apr; 15(4):317-30. PubMed ID: 8055548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
    Fujio H; Nakamura K; Matsubara H; Kusano KF; Miyaji K; Nagase S; Ikeda T; Ogawa A; Ohta-Ogo K; Miura D; Miura A; Miyazaki M; Date H; Ohe T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):250-5. PubMed ID: 16495763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.